A Comparative Study of Clinicopathological and Immunohistochemistry Features among Sample of Young Patients with Breast Cancer (≤35 years) and Older (> 35 years)

Yasir, Suha Hazim; Abd Al Shaheed, Ahmad Mubarak

doi:10.52573/ipmj.2024.183820

	A Comparative Study of Clinicopathological and Immunohistochemistry Features among Sample of Young Patients with Breast Cancer (≤35 years) and Older (> 35 years)
Iraqi Postgraduate Medical Journal
Article 18, Volume 23, Issue 2, April 2024, Pages 246-253 PDF (832.62 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2024.183820
Authors
Suha Hazim Yasir^* ¹; Ahmad Mubarak Abd Al Shaheed²
¹Babil Oncology Center, Babylon, Iraq
²Oncology Teaching Hospital/Medical City Complex/ Baghdad, Iraq
Abstract
BACKGROUND: Breast cancer is the most common malignancy and the leading cause of cancer-related deaths among women worldwide. In Iraq, breast cancer ranks the first among the top ten malignant neoplasm affecting the community. During 2016, 897 women died from the disease, and registered as the first cause of cancer related mortality among Iraqi females (23.6%) and second to bronchogenic cancer (12.1%) among males and females, and this study aimed to evaluate the clinicopathological, immunohistochemistry features of patients with breast cancer ≤ 35 years, in comparison to those > 35 years, and the impact of age on their prognosis. PATIENTS AND METHODS: In this retrospective study, medical reports of 220 patients with a known breast cancer, in Baghdad Oncology Teaching Hospital/ Medical City and Babylon oncology center databases were reviewed between February 2017and February 2019. Patients were divided into two groups RESULTS: Patients ≤35 years whom had menarche at age ≥ 14 years old were surprisingly higher 19 (17.3%) as compared to patients >35 years 7 (6.4%).according to age, 110 patients aged ≤ 35 years and 110 patients aged > 35 years old. Most patients at both age group had their first baby within age 20-25 years, while 30 patients (27.3%) ≤ 35 years had their first baby at age 25-29 years old, which was higher than older patients within same age group. Most of patients presented with grade II disease in both age group ,but 21 (19.1%) of patients ≤35 had grade I disease higher than in >35 years old 1 (0.9%) which was unusual finding as most of younger patients presented with grade III disease. Positive lymph node involvement was found to be higher in 85 patients ≤35 years(77.3%), while it was positive in 61 patients (55.5%) in older than 35 years old. HER-2 expression was higher in 23 patients (20.9%) who were ≤35 years old, while it was positive in 13 patients (11.8%) older than 35 years. CONCLUSION: Breast cancer among young females as proved is quite heterogeneous disease ,and the differences when compared to older females regarding tumor characteristics include clinicopathological, immunohistochemistry features suggest opportunities for further researches to deal with younger age as a distinct group.
Keywords
different age group breast cancer; clinicopathological features; immunohistochemistry features
Supplementary Files 17.pdf
References
International Agency for Reasearch onCancer/ World Health Organization Available at: http://globocan.iarc.fr/ia/world/atlas.html (accessed 1 February 2014). Annual Report. Iraqi Cancer Registry 2016. Iraqi Cancer Board, Ministry of Health and Environment, Republic of Iraq, 2018. Gabriel CA, Domchek SM. Breast cancer in young women. Breast cancer research. 2010 ;12:212. Zeeshan S, Ali B, Ahmad K, Chagpar AB, Sattar AK. Clinicopathological features of young versus older patients With breast cancer at a single Pakistani institution and a comparison with a national US database. Journal of global oncology. 2019;5:1-6. Wei XQ, Li X, Xin XJ, Tong ZS, Zhang S. Clinical features and survival analysis of very young (age< 35) breast cancer patients. Asian Pacific Journal of Cancer Prevention. 2013;14:5949-52. Thapa B, Singh Y, Sayami P, et al. Breast cancer in young women from a low risk population in Nepal. Asian Pac J Cancer Prev, 2013;14:5095-99. Bakkach J, Mansouri M, Derkaoui T, Loudiyi A, Fihri M, Hassani S, Barakat A, Nourouti NG, Mechita MB. Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco. BMC women's health. 2017;17:106. Pierce LJ, Levin AM, Rebbeck TR, et al. Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. J Clin Oncol. 2006;24:2437–43. PMID: 16636335. Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016;374:454–68. PMID: 26840135. 10.Swain SM, Jeong JH, Geyer CE Jr, Costantino JP, Pajon ER, Fehrenbacher L, Atkins JN, Polikoff J, Vogel VG, Erban JK, Rastogi P, Livingston RB, Perez EA, Mamounas EP, Land SR, Ganz PA, Wolmark N: Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010; 362:2053-65. 11.Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ: Incidence and time course of bleeding after longterm amenorrhea after breast cancer treatment: a prospective study. Cancer 2010;116:3102-111. 12.Rippy EE, Karat IF, Kissin MW: Pregnancy after breast cancer: the importance of active counselling and planning. Breast 2009;18:345-50. 13.Khalel EA, Alwan NA, Mustafa AA. Imaging and clinicopathological characteristics of breast cancer among women under the age of 40 years. Journal of the Faculty of Medicine. 2016;58:140-45. 14.Rodriquez A, Chew H, Cress R, et al. Evidence of poorer survival in pregnancy associated breast cancer. Obstet Gyneco 2008; 112:71-80. 15.Kataoka A, Tokunaga E, Masuda N, Shien T, Kawabata K, Miyashita M. Clinicopathological features of young patients (< 35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study. Breast cancer. 2014;21:643-50.
Statistics Article View: 271 PDF Download: 86